HIGHLIGHTS
- who: BioMed Central and collaborators from the 9107, USA, Center for Translational Medicine, Department of Medicine, Thomas Jefferson have published the Article: Bio Med Central, in the Journal: (JOURNAL)
- what: The aim of this study was to determine if FTI could be used to inhibit the inflammatory activities of a known Ras-activating human oncoprotein RET/PTC3. Methods: For the studies described here an in vitro assay was developed to measure FTI inhibition of RET/PTC3 pro-inflammatory effects. The authors postulate that the effects the authors have demonstrated with these experiments are due to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.